XML 44 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Supplemental Disclosures to the Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Cash Flows (Tables)
3 Months Ended
Mar. 31, 2024
Supplemental Disclosures to the Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Cash Flows  
Summary of Current Accrued Liabilities

Current accrued liabilities consisted of the following at the dates indicated (in thousands):

    

March 31, 

December 31, 

2024

2023

Accrued lease operating expense

$

11,440

$

14,239

Accrued liability - pipeline incident

2,670

9,331

Accrued liability - current portion of pipeline incident settlement

2,000

2,000

Accrued capital expenditures

6,500

8,019

Accrued general and administrative expense

 

2,159

 

5,335

Accrued production and ad valorem tax

 

3,659

 

3,502

Accrued commitment fee and other expense

 

2,478

 

2,626

Operating lease liability

1,740

1,737

Asset retirement obligations

 

1,493

 

1,493

Accrued current income tax payable

1,395

Accrued interest payable

284

1,792

Other

 

958

 

797

Accrued liabilities

$

36,776

$

50,871

Summary of accounts receivable

Accounts receivable consisted of the following at the dates indicated (in thousands):

    

March 31, 

December 31, 

2024

2023

Oil and natural gas receivables

$

31,570

$

31,131

Insurance receivable - pipeline incident

1,437

3,571

Joint interest owners and other

5,207

6,042

Total accounts receivable

 

38,214

 

40,744

Less: allowance for doubtful accounts

 

(1,674)

 

(1,648)

Total accounts receivable, net

$

36,540

$

39,096

Summary of Supplemental Cash Flows

Supplemental cash flows for the periods presented (in thousands):

    

For the Three Months Ended

March 31, 

2024

2023

Supplemental cash flows:

  

  

Cash paid for interest, net of amounts capitalized

$

3,920

$

4,502

Noncash investing and financing activities:

 

 

 

Increase (decrease) in capital expenditures in payables and accrued liabilities

 

 

(1,520)

 

1,966